CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

15 hedge funds and large institutions have $8.44M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 4 closing their positions.

Holders
15
Holders Change
-5
Holders Change %
-25%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
7
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BL
1
BCWM LLC
Kansas
$6.92M 577,414 +25,830 +5%
Citadel Advisors
2
Citadel Advisors
Florida
$312K 26,011 +12,390 +91%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$221K 18,415 -3,194 -15%
LPL Financial
4
LPL Financial
California
$207K 17,279 -591 -3%
Vontobel Holding
5
Vontobel Holding
Switzerland
$200K 16,681
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$176K 14,671 -22,490 -61%
PAG
7
Private Advisor Group
New Jersey
$147K 12,255 -500 -4%
PFS
8
Prospera Financial Services
Texas
$120K 10,000
Morgan Stanley
9
Morgan Stanley
New York
$48.4K 4,037 -860 -18%
Osaic Holdings
10
Osaic Holdings
Arizona
$45.4K 3,785 -36 -0.9%
BBPWM
11
Blue Bell Private Wealth Management
Pennsylvania
$20.5K 1,707
UBS Group
12
UBS Group
Switzerland
$17.8K 1,482 -1,262 -46%
SWA
13
SOA Wealth Advisors
New York
$1.8K 150
NA
14
NewEdge Advisors
Louisiana
$120 10
Wells Fargo
15
Wells Fargo
California
CG
16
Colony Group
Massachusetts
-17,598 Closed
RIA
17
Realta Investment Advisors
Delaware
-539 Closed
BAM
18
Belpointe Asset Management
Nevada
-460 Closed
Northwestern Mutual Wealth Management
19
Northwestern Mutual Wealth Management
Wisconsin
-10 Closed
BAM
20
Baldrige Asset Management
Pennsylvania
$0 37
CFGS
21
Concourse Financial Group Securities
Alabama